Enlivex Therapeutics Ltd.
ENLV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15 | -$29 | -$31 | -$14 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | -$6 |
| Stock-Based Comp. | $0 | $2 | $3 | $3 |
| Change in WC | -$1 | -$2 | $1 | -$1 |
| Other Non-Cash | $3 | $5 | $3 | $0 |
| Operating Cash Flow | -$13 | -$24 | -$24 | -$18 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$8 | -$2 |
| Net Acquisitions | $0 | $0 | -$10 | -$20 |
| Inv. Purchases | -$32 | -$26 | -$2 | -$104 |
| Inv. Sales/Matur. | $39 | $0 | $72 | $68 |
| Other Inv. Act. | $2 | $0 | $10 | $20 |
| Investing Cash Flow | $9 | -$26 | $63 | -$38 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $6 | $0 | $0 | $53 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $8 |
| Financing Cash Flow | $6 | $0 | $0 | $61 |
| Forex Effect | $0 | $0 | $0 | -$0 |
| Net Chg. in Cash | $3 | -$49 | $39 | $5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $50 | $12 | $7 |
| End Cash | $4 | $1 | $50 | $12 |
| Free Cash Flow | -$13 | -$24 | -$32 | -$19 |